99%纯度肽2mg /小瓶Tb500肌肉建设
| 型号。 | SYB-420 |
| 证明 | gmp,iso 9001 |
| 纯度 | >97% |
| 规范 | GMP |
| HS编码 | 62833 |
| 粉末 | 是 |
| 州 | 粉末 |
| 商标 | 沉义生物技术 |
| 起源 | 广州 |
99%Purity Peptide 2mg / vial TB500 for Muscle Building |
| CAS:77591-33-4胸腺素β4乙酸酯(TB500)(Bulk Raw)(2mg /小瓶,10份/试剂盒) 序列:AC-Ser-Asp-Lys-PRO-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-谷氨酸 - 赖氨酸 - 天冬酰胺-PRO-LEU-PRO-SER-赖氨酸谷氨酸 - 苏氨酸 - 异亮氨酸 - 谷氨酸 - 谷氨酰胺 - 谷氨酸 - 赖氨酸 - 谷氨酰胺 - 丙氨酸 - 甘氨酸 - 谷氨酸-SER-OH cas号码:77591-33-4 分子式:C212H350N56O78S 分子量:4963.49 纯度(HPLC):95%min 单一杂质(HPLC):最大2.0% 氨基酸组成:理论值的±10%oretical 肽含量(N%):≥80.0%0.0%0.0% 含水量(卡尔费休):≤5.0%5.0%5.0% 醋酸含量(HPIC):≤15.0%5.0%5.0% MS(ESI):一致 质量平衡:95.0〜105.0% 外观:白色粉末 |
名称 | 10vials /试剂盒 | cas代码 |
| CJC-1295 | 为2mg /瓶 | 863288-34-0 |
| cjc-1295 dac | 为2mg /瓶 | 863288-34-0 |
| GHRP-2 | 为10mg /瓶 | 158861-67-7 |
| GHRP-2 | 5毫克/瓶 | 158861-67-7 |
| GHRP-6 | 为10mg /瓶 | 87616-84-0 |
| GHRP-6 | 5毫克/瓶 | 87616-84-0 |
| MGF | 为2mg /瓶 | - |
| PEG-MGF | 为2mg /瓶 | - |
| 布美诺肽; PT-141 | 为10mg /瓶 | 189691-06-3 |
| 瑞林 | - | 79561-22-1 |
| 醋酸六环素 | 为2mg /瓶 | 140703-51-1 |
| 伊帕瑞林 | 为2mg /瓶 | - |
| 伊帕瑞林 | 5毫克/瓶 | - |
| EGRIFTA(Tesamorelin) | 为2mg /瓶 | - |
| 醋酸亮丙瑞林euprolide | - | 53714-56-0 |
| 醋酸纤维素 | - | 86168-78-7 |
| 醋酸曲普瑞林 | 为2mg /瓶 | 57773-63-4 |
| 曲普瑞林100mcg GNRH | - | - |
| 黑曲霉I(MT-1) | 为10mg /瓶 | 75921-69-6 |
| 黑色素II(MT-II) | 为10mg /瓶 | 121062-08-6 |
| 醋酸催产素; Oxtocin | 为2mg /瓶 | 50-56-6 |
| 胸腺素β4乙酸(TB500)TB500)TB500) | 为2mg /瓶 | 77591-33-4 |
| DSIP(三角洲睡眠诱导eptide) | 为2mg /瓶 | - |
| 醋酸甘宁酯 | - | 123246-29-7 |
英文名 | CAS编号 | 内容 |
| 类药 | 72-63-9 | 97-103% |
| Stanozolo ** | 10418-03-8 | 98.0-100.5% |
| Ciali ** | 171596-29-5 | ≥99%99%99 % |
| Oxandrolon ** | 53-39-4 | 97.0-100.5% |
| 醋酸泼沸石 | 10161-34-9 | 97-101% |
| 西地那非**柠檬酸盐 | 171599-83-0 | 98-101% |
| 戊酸叔戊醇酯 | 472-61-546 | 97.0-101.0% |
| 乙酸氯己定 | 56-95-1 | cp 99% |
| Oxymetholon-E | 434-07-1 | 97-103% |
| 氨甲环酸 | 1197-18-8 | 99-101% |
| 茴香醛 | 123-11-5 | 99.50% |
| 17,甲睾酮 | 58-18-4 | 97%-103% |
| 丙酸消旋酮 | 521-12-0 | ≥97%; 97%;97% |
| 1脱氢-4-氯-17-甲 | 2446-23-3 | ≥97%; 97%;97% |
| 戊酸甲酚酚 | 303-42-4 | ≥98%98%;98% |
| Permastril | 521-12-0 | ≥97%; 97%;97% |
| 2-苯基咪唑 | 670-96-2 | 99% |
| 酮康唑 | 65277-42-1 | 99% |
| 盐酸苯海明 | 834-28-6 | 99% |
| Mesteronlone | 1424-00-6 | 98-102% |
| 醋酸甲氧酚 | 434-05-9 | 97-102% |
| L-甘氨酸 | 56-40-6 | 98.5-101.0% |
| Stanolone | 521-11-9 | ≥97%; 97%;97% |
| 6- Bronmandrostenedione | 38632-00-7 | 97% |
| Dehydroepiandrosteron-E | 53-43-0 | 98% |
| 醋酸脱氢表雄酮 | 853-23-6 | 98% |
| 睾酮-E | 58-22-0 | 98% |
| Androstenedion-E | 1963-5-8 | 98% |
| 丙酸睾酮 | 58-20-8 | 98% |
| 癸酸睾酮 | 5721-91-5 | 98% |
| 雄激素雄激素 | ||
| 丙酸雄甾醇酮 | ||
| 异睾酮睾丸激素 | 15262-86-9 | 98% |
| 苯丙酸睾酮 | 1255-49-8 | 98% |
| 十八碳烯酸胆固醇 | 13103-34-9 | 98% |
| Nandrolon-E | 434-22-0 | 97% |
| 癸酸癸酯 | 360-70-3 | 98% |
| 庚酸睾酮 | 315-37-7 | 98% |
| 丙酸睾酮 | 57-85-2 | 98% |
| Boldenon-E | 846-48-0 | 98% |
| 睾酮维生素 | ||
| 十一酸睾酮 | 5949-44-0 | 98% |
| 雌二醇 | 50-28-2 | 98% |
| 17-庚酸雌二醇酯 | 4956-37-0 | 98% |
| Androstenedio-1 | 521-17-5 | 95% |
| 雌二醇苯甲酸酯 | 50-50-0 | 98% |
| 苯丙酸诺德洛尔 | 62-90-8 | 98% |
| 醋酸睾酮 | 1045-69-8 | 98% |
| 十八碳烯酸胆固醇 | 98% | |
| 醋酸4-氯otes酮 | 855-19-6 | 98% |
| 槟榔碱 | 106505-90-2 | 98% |



| Model NO. | SYB-420 |
| Certification | GMP, ISO 9001 |
| Purity | >97% |
| Specification | GMP |
| HS Code | 62833 |
| Powder | Yes |
| State | Powder |
| Trademark | ShenYi Biotechnology |
| Origin | Guangzhou |
99% Purity Peptide 2mg/vial TB500 for Muscle Building |
| CAS: 77591-33-4 Thymosin Beta4 Acetate (TB500) (Bulk Raw) (2mg/vial,10vial/kit) Sequence: AC-Ser-Asp-Lys-PRO-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-PRO-Leu-PRO-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH CAS No.: 77591-33-4 Molecular Formula: C212H350N56O78S Molecular Weight: 4963.49 Purity (HPLC): 95%min Single Impurity (HPLC): 2.0%max Amino Acid Composition: ± 10% of theoreticaloreticaloretical Peptide Content (N%): ≥ 80.0%0.0%0.0% Water Content(Karl Fischer): ≤ 5.0%5.0%5.0% Acetate Content (HPIC): ≤ 15.0%5.0%5.0% MS(ESI): Consistent Mass Balance: 95.0~105.0% Appearance: White powder |
Name | 10vials/kit | CAS Code |
| CJC-1295 | 2mg/vial | 863288-34-0 |
| CJC-1295 DAC | 2mg/vial | 863288-34-0 |
| GHRP-2 | 10mg/vial | 158861-67-7 |
| GHRP-2 | 5mg/vial | 158861-67-7 |
| GHRP-6 | 10mg/vial | 87616-84-0 |
| GHRP-6 | 5mg/vial | 87616-84-0 |
| MGF | 2mg/vial | - |
| PEG-MGF | 2mg/vial | - |
| Bremelanotide; PT-141 | 10mg/vial | 189691-06-3 |
| Alarelin | - | 79561-22-1 |
| Hexarelin Acetate | 2mg/vial | 140703-51-1 |
| Ipamorelin | 2mg/vial | - |
| Ipamorelin | 5mg/vial | - |
| Egrifta(Tesamorelin) | 2mg/vial | - |
| Leuprorelin Acetate; euprolide | - | 53714-56-0 |
| Sermorelin Acetate | - | 86168-78-7 |
| Triptorelin Acetate | 2mg/vial | 57773-63-4 |
| Triptorelin 100mcg GNRH | - | - |
| Melanotan-I (MT-I) | 10mg/vial | 75921-69-6 |
| Melanotan-II (MT-II) | 10mg/vial | 121062-08-6 |
| Oxytocin Acetate; Oxtocin | 2mg/vial | 50-56-6 |
| Thymosin β4 Acetate (TB500)TB500)TB500) | 2mg/vial | 77591-33-4 |
| DSIP (Delta sleep-inducing eptide) | 2mg/vial | - |
| Ganirelix Acetate | - | 123246-29-7 |
English name | CAS number | content |
| Metandienone | 72-63-9 | 97-103% |
| Stanozolo** | 10418-03-8 | 98.0-100.5% |
| Ciali** | 171596-29-5 | ≥99 %99 %99 % |
| Oxandrolon** | 53-39-4 | 97.0-100.5% |
| Trenbolone acetate | 10161-34-9 | 97-101% |
| Sildenafi** citrate | 171599-83-0 | 98-101% |
| Ternbolone Enanthate | 472-61-546 | 97.0-101.0% |
| Chlorhexidine acetate | 56-95-1 | CP 99% |
| Oxymetholon-e | 434-07-1 | 97-103% |
| Tranexamic acid | 1197-18-8 | 99-101% |
| Anisic aldehyde | 123-11-5 | 99.50% |
| 17-Methyltestosterone | 58-18-4 | 97%-103% |
| Dromostanolone propionate | 521-12-0 | ≥97%;97%;97% |
| 1-Dehydro-4-chloro-17-methyltestosterone | 2446-23-3 | ≥97%;97%;97% |
| Methenolone enanthate | 303-42-4 | ≥98%;98%;98% |
| Permastril | 521-12-0 | ≥97%;97%;97% |
| 2-Phenylimidazole | 670-96-2 | 99% |
| Ketoconazole | 65277-42-1 | 99% |
| Phenformin hydrochloride | 834-28-6 | 99% |
| Mesteronlone | 1424-00-6 | 98-102% |
| Methenolone acetate | 434-05-9 | 97-102% |
| L-glycine | 56-40-6 | 98.5-101.0% |
| Stanolone | 521-11-9 | ≥97%;97%;97% |
| 6-Bronmandrostenedione | 38632-00-7 | 97% |
| Dehydroepiandrosteron-e | 53-43-0 | 98% |
| Dehydroepiandrosterone acetate | 853-23-6 | 98% |
| Testosteron-e | 58-22-0 | 98% |
| Androstenedion-e | 1963-5-8 | 98% |
| Testosterone cypionate | 58-20-8 | 98% |
| Testosterone decanoate | 5721-91-5 | 98% |
| Drostanolone enanthate | ||
| Drostanolone propionate | ||
| Testosterone isocaproate | 15262-86-9 | 98% |
| Testosterone phenylpropionate | 1255-49-8 | 98% |
| Boldenone undecylenate | 13103-34-9 | 98% |
| Nandrolon-e | 434-22-0 | 97% |
| Nandrolone decanoate | 360-70-3 | 98% |
| Testosterone enanthate | 315-37-7 | 98% |
| Testosterone propionate | 57-85-2 | 98% |
| Boldenon-e | 846-48-0 | 98% |
| Testosterone sustanon | ||
| Testosterone undecanoate | 5949-44-0 | 98% |
| Estradiol | 50-28-2 | 98% |
| Oestradiol 17-heptanoate | 4956-37-0 | 98% |
| Androstenedio-l | 521-17-5 | 95% |
| Estradiol benzoate | 50-50-0 | 98% |
| Nandrolone phenylpropionate | 62-90-8 | 98% |
| Testosterone acetate | 1045-69-8 | 98% |
| Boldenone undecylenate | 98% | |
| 4-Chlorotestosterone acetate | 855-19-6 | 98% |
| BOLDENONE CYPIONATE | 106505-90-2 | 98% |


